Therapeutic effects of fengabine, a new GABAergic agent, in depressed outpatients: a double‐blind study versus clomipramine

Niels Peter Nielsen, B.M. Cesana, S Zizolfi, V. Ascalone, Paola Priore, P. L. Morselli

Acta Psychiatrica Scandinavica · 1990 · 21 citations · 14 references

Concepts

Abstract

The results of a double-blind clinical trial of fengabine vs clomipramine in depressed outpatients are reported. Fengabine, a new GABAergic agent, seems to be as effective as the reference drug, with a faster onset of action and a more marked effect on cognitive disturbances and retardation. The new drug is free of any significant anticholinergic or cardiovascular effect, and it is not sedative.

References

14